A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours Meeting Abstract
| Authors: | Schram, A. M.; Drilon, A.; Macarulla Mercade, T.; O'Reilly, E. M.; Rodon, J. A.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C. H.; Lam, Y. C. J.; Varga, A.; de Langen, A. J.; Witteveen, P. O.; Boni, V.; Cerea, G.; Duruisseaux, M.; Liu, S. V.; Wasserman, E.; Hyman, D. M.; Tabernero, J. |
| Abstract Title: | A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz247.169 |
| Language: | English |
| ACCESSION: | WOS:000491295502115 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz247.169 |
| Notes: | Meeting Abstract: 685TiP -- Appears on page v317 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
